4 Dimensional - Impairment of Posttraumatic Forearm Rotation Evaluated With Computed Tomography
NCT ID: NCT04067232
Last Updated: 2022-12-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5 participants
INTERVENTIONAL
2020-01-16
2020-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with posttraumatic forearm impairment
All patients with a one-sided posttraumatic impairment of forearm pro- and/or supination at least 3 months after injury
4D-CT-scan
Both forearms of the subjects with posttraumatic forearm impairment are scanned with a 4D-CT scanning technique, during forearm rotation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
4D-CT-scan
Both forearms of the subjects with posttraumatic forearm impairment are scanned with a 4D-CT scanning technique, during forearm rotation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients are above 18 years
* Patients who are willing to give informed consent
* National health insurance cover
Exclusion Criteria
* Any shoulder pathology or impairment preventing forward elevation of the arm as required during the scanning protocol
* Neuromuscular pathology
* Not able to understand or give informed consent
* Pregnancy (βHCG positive), breast-feeding or the absence of effective contraception for women of child-bearing age
* Legal incapacity (persons in custody or under guardianship)
* Deprived of liberty Subject (by judicial or administrative decision)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Geert BUIJZE, MD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF 7729
Identifier Type: OTHER
Identifier Source: secondary_id
RECHMPL18_0463
Identifier Type: -
Identifier Source: org_study_id